Medline, Inc. Class A MDLN 深 沪
交易中 01-30 10:15:02 美东时间
44.25
+0.520
+1.19%
华盛通- 最 高44.83
- 今 开43.93
- 成交量 17.09万股
- 最 低 43.86
- 昨 收 43.73
- 总市值 359.05亿
- 52周最高 46.90
- 市盈率 静 29.49
- 换手率 0.02%
- 52周最低 34.89
- 委 比 2.44%
- 总股本 8.11亿
- 历史最高 46.90
- 量 比 0.71
- 振 幅 2.22%
- 历史最低 34.89
- 每 手 1
- 风险率 3.15%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Jim Cramer Says Sell Super Micro — Calls A European Chipmaker 'Cheap And Good'
Jim Cramer recommended selling Super Micro Computer Inc. and doesn't recommend Alkermes plc. Huntington Bancshares is 'terrific.' Smith & Nephew plc should be sold. Cramer also recommends buying Medline Inc. and STMicroelectronics N.V.
01-20 22:02
美股盘后 | StandardAero, Inc.涨6.90%，可口可乐凡萨瓶装涨2.10%
StandardAero, Inc.涨6.90%；可口可乐凡萨瓶装涨2.10%；Equinox Gold Corp.涨2.04%
01-17 07:10
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
Analysts Say Medline Has The Secret Sauce For Sustained Growth
Medline received favorable coverage from several analysts. It recently raised $7 billion in an IPO and has a strong product portfolio.
01-13 02:59
BTIG Initiates Coverage On Medline with Buy Rating, Announces Price Target of $50
BTIG analyst David Larsen initiates coverage on Medline (NASDAQ:MDLN) with a Buy rating and announces Price Target of $50.
01-12 18:05
年终盘点丨2025年港股强劲复苏，美股延续强势，白银暴涨142%碾压全场，一图回顾全年行情
2025年港股强劲复苏，美股延续强势！白银暴涨142%碾压全场，AI浪潮引爆造富神话多股狂涨超300%！一图回顾全年行情>>
01-08 15:36
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
The Benzinga Stock Whisper Index highlights five stocks seeing increased interest from readers and looks at catalysts that could be driving the attention.
01-04 22:36
年终盘点 | 7倍涨幅！2025美股新股王诞生！存储芯片巨头SanDisk升逾585%仅排第二
2025最意外的美股IPO黑马！供应链金融公司Diginex暴涨超7倍登顶，存储芯片巨头SanDisk升逾585%仅排第二，今年最大IPO Medline涨超44%>>
2025-12-31 13:41
Medline Announces Participation in J.P. Morgan 2026 Healthcare Conference
Medline Inc. announced that CEO Jim Boyle and CFO Mike Drazin will present at the J.P. Morgan Healthcare Conference in San Francisco on January 13, 2026. The presentation will be available on Medline’s Investor Relations website, with a replay accessible for 30 days post-event. Medline is the largest provider of medical-surgical products and supply chain solutions, serving healthcare providers globally.
2025-12-30 21:05
Medline Inc. Completes IPO and Implements Governance Changes
The latest update is out from Medline, Inc. Class A ( ($MDLN) ). On December 16...
2025-12-23 06:19
